Over the years, pharmacovigilance (PV) processes have relied on PV professionals manually sifting through large volumes of data to identify, assess, and report Adverse Event (AE) informatio
In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Brigham Hyde, co-founder and CEO of Atropos Health, and Ardy Arianpour, co-founder and CEO of SEQSTER, about